High Tower Advisors, LLC Heron Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 16,728 shares of HRTX stock, worth $28,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,728
Previous 12,529 33.51%
Holding current value
$28,437
Previous $43,000 23.26%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.73 - $3.67 $7,264 - $15,410
4,199 Added 33.51%
16,728 $33,000
Q2 2024

Aug 13, 2024
SELL
$2.32 - $3.86 $69,600 - $115,800
-30,000 Reduced 70.54%
12,529 $43,000
Q1 2024

May 06, 2024
SELL
$1.71 - $3.06 $51,354 - $91,897
-30,032 Reduced 41.39%
42,529 $117,000
Q4 2023

Feb 12, 2024
BUY
$0.54 - $1.82 $33,372 - $112,477
61,801 Added 574.36%
72,561 $123,000
Q3 2023

Nov 08, 2023
BUY
$0.97 - $1.8 $10,437 - $19,368
10,760 New
10,760 $11,000
Q3 2020

Nov 13, 2020
SELL
$13.67 - $17.77 $134,266 - $174,536
-9,822 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$10.89 - $21.47 $106,961 - $210,878
9,822 New
9,822 $145,000
Q1 2020

May 21, 2020
SELL
$10.23 - $24.56 $126,463 - $303,610
-12,362 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$17.42 - $26.61 $7,960 - $12,160
457 Added 3.84%
12,362 $290,000
Q3 2019

Nov 12, 2019
BUY
$16.36 - $21.39 $15,934 - $20,833
974 Added 8.91%
11,905 $223,000
Q2 2019

Aug 13, 2019
SELL
$16.93 - $26.22 $74,424 - $115,263
-4,396 Reduced 28.68%
10,931 $205,000
Q1 2019

May 15, 2019
SELL
$23.15 - $28.34 $69,172 - $84,679
-2,988 Reduced 16.31%
15,327 $373,000
Q4 2018

Feb 14, 2019
BUY
$22.03 - $32.01 $1,365 - $1,984
62 Added 0.34%
18,315 $477,000
Q3 2018

Nov 09, 2018
SELL
$30.0 - $40.85 $30,000 - $40,850
-1,000 Reduced 5.19%
18,253 $576,000
Q2 2018

Aug 14, 2018
SELL
$26.4 - $42.0 $25,106 - $39,942
-951 Reduced 4.71%
19,253 $749,000
Q1 2018

May 15, 2018
SELL
$18.43 - $28.8 $159,880 - $249,840
-8,675 Reduced 30.04%
20,204 $560,000
Q4 2017

Feb 14, 2018
BUY
$14.8 - $18.85 $125,726 - $160,130
8,495 Added 41.67%
28,879 $522,000
Q3 2017

Nov 14, 2017
BUY
$14.65 - $16.85 $55,670 - $64,030
3,800 Added 22.91%
20,384 $327,000
Q2 2017

Aug 14, 2017
BUY
N/A
16,584
16,584 $231,000

Others Institutions Holding HRTX

# of Institutions
175
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $202M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email